| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Research Abstract |
It is not possible that development of new radiopharmaceutical proceed freely because a limit of the energy that can be measured in the nuclear medicine diagnosis equipment. Therefore, we have been promoting the development Electron Tracking Compton Gamma-ray Camera (ETCC) for nuclear medicine and molecular imaging.ETCC can choose any nuclear species for imaging because of no energy limit, it can be developed freely using RI drug candidates over several 10 species that can not be caught in the conventional nuclear medicine camera.
And developed with the goal of improving the performance of the ETCC, we got an important finding in the present application. It is believed that this development will be significantly expanding the field of RI-drug development for nuclear medicine and molecular imaging, and will help many patients.
|
